- About Us
- Media Release
- Our Clients
- Media Mentions
- Subscription Model
- Contact Us
The Asia Pacific Blood Purification Equipment Market would witness market growth of 6% CAGR during the forecast period (2020-2026). In the last few years, plenty of therapeutic technologies & advanced blood purification machines have penetrated the market. Rising knowledge-based and awareness regarding hematology & pathophysiology due to high R&D along with remarkable advancements in bio separation methods is some of the aspects that would support the growth of the blood purification equipment market.
Moreover, the latest developments in pathophysiology of various diseases have brought a surge in the adoption of blood purification techniques has and hence, fueled the demand for blood purification equipment. The findings of various pathophysiology agents in the bloodstream & their essential role in the pathophysiology of associated diseases such as systematic inflammatory response syndrome, autoimmune diseases, dialysis-related amyloidosis (DRA), & cancer would open growth avenues for the blood purification equipment market during the forecast period.
The demand for blood purification techniques has observed substantial development in the past few years and is extensively utilized to treat various disorders, which cannot be treated by traditional methods, such as drug administration and surgery. The advancements made by bio separation methods, such as dialysis, filtration, and adsorptions are one of the leading trends that would fuel the growth of the blood purification equipment market during the forecast period. Blood purification techniques provide superior efficiency in the quick and direct removal of pathogenic agents due to which, their adoption is increasing in various parts of the world.
The China market dominated the Asia Pacific Hospitals and Clinics Market by Country in 2019, and would continue to be a dominant market till 2026. The India market is anticipated to grow at a CAGR of 7.2% during (2020 - 2026). Additionally, The Japan market is showcasing a CAGR of 7.3% during (2020 - 2026).
The Portable market dominated the Malaysia Blood Purification Equipment Market by Product in 2019, thereby, achieving a market value of $289.7 million by 2026. The Stationary market would exhibit a CAGR of 8.1% during (2020 - 2026).
Based on Product, the market is segmented into Portable and Stationary. Based on Indication, the market is segmented into Renal Diseases, Sepsis and Other Equipments. Based on End User, the market is segmented into Dialysis Centers, Hospitals and Clinics and Other End Users. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include B. Braun Melsungen AG, Baxter International, Inc., Asahi Kasei Corporation, Nikkiso Co., Ltd., Kaneka Corporation, Cerus Corporation, Shanwaishan Medical Group, Jafron Biomedical Co., Ltd., Infomed SA, and Fresenius SE & Co. KGaA.
By End User
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.